Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Accueil Zonebourse  >  Actions  >  Euronext Paris  >  NicOx SA    NCOX   FR0000074130

NICOX SA (NCOX)

Mes dernières consult.
Top consultations
1736
SynthèseGraphiquesActualitésAnalysesAgendaSociétéFinancesConsensusRévisionsFondsCommunauté 
Métier
Logo NicOx SA
Developes and manufactures biopharmaceuticals

Nicox SA is an international commercial-stage company focused on the ophthalmic market.

It seeks and evaluate commercial and late-stage ophthalmic products.

The company was founded by Piero Del Soldato, Michele Garufi and Elizabeth Marie Robinson on February 15, 1996 and is headquartered in Sophia-Antipolis, France.
Dirigeants
Nom AgeDepuisTitre
Michele Garufi621996Chairman & Chief Executive Officer
Philippe Masquida552012Executive Vice President & MD-European Operations
Sandrine Gestin491999Finance Director
Michael Bergamini, PhD-2014Chief Scientific Officer & Executive VP
Jean-François Labbé, MBA662010Director
Birgit Stattin Norinder692011Director
Adrienne L. Graves, PhD622014Director
Luzi Andreas von Bidder642014Director
Lester J. Kaplan, PhD662014Director
Gavin M. Spencer, PhD462005Executive Vice President-Corporate Development
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 22 949 913 22 643 897 98.7% 50 903 0.2% 98.7%
Actionnaires
Nom Actions%
Bpifrance Participations SA /PRIVATE EQUITY/ 790 514 3,16%
HBM Partners AG 325 000 1,30%
New Enterprise Associates LLC 283 094 1,13%
Highland Capital Management LP 275 682 1,10%
Michele Garufi 181 051 0,72%
Dimensional Fund Advisors LP 139 263 0,56%
OP Asset Management Ltd. 125 000 0,50%
Elizabeth Marie Robinson, PhD 74 060 0,30%
Lester J. Kaplan, PhD 69 131 0,28%
Nicox SA 50 903 0,20%
Participations
Nom Actions%Valorisation
Nicox (COX) 50 9030,20%458 029 USD
Secteur
Santé
Recherche pharmaceutique et médicale
 Produits pharmaceutiques
  Produits pharmaceutiques
   Pharmacies spécialisées et de pointe
Publicité
Secteur Pharmacies spécialisées et de pointe
Var. 1janvCapitalisation (M$)
NICOX SA-22.33%228
ABBVIE INC-1.21%100 529
MERCK KGAA3.08%14 107
KYOWA HAKKO KIRIN CO L..-2.78%8 000
JAZZ PHARMACEUTICALS P..6.00%6 922
MALLINCKRODT PLC-0.80%5 232
ZHANGZHOU PIENTZEHUANG..-0.68%3 983
INDIVIOR PLC2.70%2 626
YUHAN CORPORATION--.--%2 022
MAYNE PHARMA GROUP LTD-6.69%1 416
SUPERNUS PHARMACEUTICA..-5.74%1 178
ADVANCED ACCELERATOR A..--.--%1 135
THERAPEUTICSMD INC0.87%1 128
KNIGHT THERAPEUTICS IN..-4.11%1 120
EAGLE PHARMACEUTICALS ..-12.05%1 077
REPLIGEN CORPORATION-3.60%1 005
AIMMUNE THERAPEUTICS I..-4.84%974
LG LIFE SCIENCES, LTD--.--%968
NICHI-IKO PHARMACEUTIC..1.43%908
STALLERGENES GREER13.92%744
DONG-A ST CO LTD--.--%684
Secteur Pharmacies spécialisées et de pointe
NicOx SA : Connexions
Himalayan Cataract Project
Keck Graduate Institute of Applied Life Sciences
Aciex Therapeutics, Inc.
Partners för Utvecklingsinvesteringar inom Life Sciences AB
Wingfirm Pharma AB
KeepYourSight Foundation
The Association for Research in Vision & Ophthalmology
Navigation Dynamics AB
The Clinical Research Institute of the Foundation
Wntresearch AB
Delife SRL
American Glaucoma Society
Pan-American Ophthalmological Foundation
Envisia Therapeutics, Inc.
Relivia SRL
American Academy of Ophthalmology, Inc.
Women in Ophthalmology
Ferring Holding SA
American Academy of Ophthalmology Foundation
Ferring International Center SA
The American Society of Cataract & Refractive Surgery
Neurotech Pharmaceuticals, Inc. (United States)
Glaucoma Research Foundation
Medinox, Inc.
Aerpio Therapeutics, Inc.
FFB Clinical Research Institute
Coordonnées société
Nicox SA
Drakkar 2 - Bât D
2405 route des Dolines
Sophia-Antipolis, Provence-Alpes-Cote-dAzur 06560

Phone : +33.4.97.24.53.00
Fax : +33.4.97.24.53.99
Web : www.nicox.com
© 2017 People , Fundamentals and Ownership